Luye Pharma Group 주식 주식분석 | 주식가격 | 뉴스 | 2186.HK | BMG570071099 | A116Z9

날짜	Luye Pharma Group 매출	Luye Pharma Group EBIT	Luye Pharma Group 이익
2026e	8.27 조. undefined	1.75 조. undefined	1.09 조. undefined
2025e	7.53 조. undefined	1.51 조. undefined	884.41 백만 undefined
2024e	6.79 조. undefined	1.31 조. undefined	677.21 백만 undefined
2023	6.14 조. undefined	1.03 조. undefined	532.61 백만 undefined
2022	5.98 조. undefined	916.53 백만 undefined	604.81 백만 undefined
2021	5.2 조. undefined	435.54 백만 undefined	-134.39 백만 undefined
2020	5.54 조. undefined	1.19 조. undefined	706.59 백만 undefined
2019	6.36 조. undefined	1.74 조. undefined	1.4 조. undefined
2018	5.17 조. undefined	1.52 조. undefined	1.3 조. undefined
2017	3.81 조. undefined	1.09 조. undefined	981.37 백만 undefined
2016	2.92 조. undefined	914.71 백만 undefined	891.54 백만 undefined
2015	2.56 조. undefined	830.93 백만 undefined	754.52 백만 undefined
2014	2.54 조. undefined	718.95 백만 undefined	605.52 백만 undefined
2013	2.52 조. undefined	402.3 백만 undefined	310.5 백만 undefined
2012	2.14 조. undefined	279.1 백만 undefined	169 백만 undefined
2011	1.77 조. undefined	218.8 백만 undefined	151.6 백만 undefined
2010	1.34 조. undefined	183 백만 undefined	136.1 백만 undefined
2009	954.8 백만 undefined	155.1 백만 undefined	123.5 백만 undefined
2008	651 백만 undefined	85.3 백만 undefined	62.1 백만 undefined
2007	509 백만 undefined	82.1 백만 undefined	58.1 백만 undefined
2006	308.3 백만 undefined	81.1 백만 undefined	83.7 백만 undefined
2005	344.4 백만 undefined	91.7 백만 undefined	89.6 백만 undefined
2004	315.4 백만 undefined	80.8 백만 undefined	71.8 백만 undefined

	매출	EBIT	이익
2004	315.4 백만 CNY	80.8 백만 CNY	71.8 백만 CNY
2005	344.4 백만 CNY	91.7 백만 CNY	89.6 백만 CNY
2006	308.3 백만 CNY	81.1 백만 CNY	83.7 백만 CNY
2007	509 백만 CNY	82.1 백만 CNY	58.1 백만 CNY
2008	651 백만 CNY	85.3 백만 CNY	62.1 백만 CNY
2009	954.8 백만 CNY	155.1 백만 CNY	123.5 백만 CNY
2010	1.34 조. CNY	183 백만 CNY	136.1 백만 CNY
2011	1.77 조. CNY	218.8 백만 CNY	151.6 백만 CNY
2012	2.14 조. CNY	279.1 백만 CNY	169 백만 CNY
2013	2.52 조. CNY	402.3 백만 CNY	310.5 백만 CNY
2014	2.54 조. CNY	718.95 백만 CNY	605.52 백만 CNY
2015	2.56 조. CNY	830.93 백만 CNY	754.52 백만 CNY
2016	2.92 조. CNY	914.71 백만 CNY	891.54 백만 CNY
2017	3.81 조. CNY	1.09 조. CNY	981.37 백만 CNY
2018	5.17 조. CNY	1.52 조. CNY	1.3 조. CNY
2019	6.36 조. CNY	1.74 조. CNY	1.4 조. CNY
2020	5.54 조. CNY	1.19 조. CNY	706.59 백만 CNY
2021	5.2 조. CNY	435.54 백만 CNY	-134.39 백만 CNY
2022	5.98 조. CNY	916.53 백만 CNY	604.81 백만 CNY
2023	6.14 조. CNY	1.03 조. CNY	532.61 백만 CNY
2024e	6.79 조. CNY	1.31 조. CNY	677.21 백만 CNY
2025e	7.53 조. CNY	1.51 조. CNY	884.41 백만 CNY
2026e	8.27 조. CNY	1.75 조. CNY	1.09 조. CNY

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.05	0.08	0.09	0.09	0.07	0.08	0.17	0.2	0.2	0.26	0.38	0.73	0.9	0.97	1.12	1.47	1.63	0.94	-0.07	0.67
10	10	11	15	40	41	44	65	74	78	95	105	109	135	243	310	455	510	581	671
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-27	-43	-56	-44	18	-16	-44	11	30	-211	-66	-519	-535	-469	-360	-822	-869	-791	-985	-142
7	4	0	-4	11	0	-2	-18	19	29	27	7	-78	-48	-34	83	202	371	660	454
6	5	2	2	16	12	8	9	22	34	26	40	13	29	51	157	207	330	297	369
5	0	0	7	10	15	22	38	59	70	78	103	111	132	195	178	176	160	270	92
0.04	0.05	0.05	0.05	0.14	0.11	0.16	0.25	0.33	0.15	0.44	0.32	0.39	0.59	0.96	1.05	1.42	1.03	0.18	1.65
-13	-11	-29	-9	-14	-44	-24	-140	-338	-147	-270	-289	-208	-319	-625	-2,484	-3,050	-1,519	-1,541	-1,163
-12	-15	-44	-343	-176	-3	-66	-194	-643	-135	-554	-2,978	240	-1,834	-743	-2,997	-2,628	138	-3,436	-1,658
0	-0	-0.02	-0.33	-0.16	0.04	-0.04	-0.05	-0.3	0.01	-0.28	-2.69	0.45	-1.52	-0.12	-0.51	0.42	1.66	-1.89	-0.49
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.02	-0.07	-0.05	0.01	0.11	-0.11	0.06	0.06	0.18	0.02	0.27	-0.44	0.2	1.12	1.24	3.28	2.33	1.44	-0.41	-0.67
0	0.1	0	0.32	-0	0	0	0	0	0	0	0	0	0	-0.46	-0.02	-0.01	-0.08	1.04	0
0	0.05	-0.06	0.32	0.09	-0.13	0.06	0.06	0.17	0.09	0.09	2.66	0.05	0.82	0.73	2.4	1.84	0.25	1.88	0.05
-0.02	0.01	-0.01	-0.02	-0.02	-0.01	0	0	-0.01	0.08	-0.19	-0.04	-0.15	-0.19	0.17	-0.56	-0.1	-0.93	1.24	0.72
0	0	0	0	0	0	0	0	0	0	0	0	0	-106	-212	-289	-376	-175	0	0
0.03	0.08	-0.06	0.03	0.05	-0.02	0.16	0.12	-0.15	0.11	-0.03	-0	0.69	-0.45	0.87	0.41	0.63	1.54	-1.43	-0.11
27.1	36.5	16.2	41.6	121.5	61.6	138.7	113.6	-13.2	5.8	168.7	29.82	186.62	272.89	338.92	-1,438.93	-1,628.33	-486.43	-1,359.22	490.14
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Luye Pharma Group 브루토마진	Luye Pharma Group 이익 마진	Luye Pharma Group EBIT-마진	Luye Pharma Group 이익 마진
2026e	68.44 %	21.2 %	13.17 %
2025e	68.44 %	20.03 %	11.75 %
2024e	68.44 %	19.24 %	9.97 %
2023	68.44 %	16.83 %	8.67 %
2022	69.22 %	15.32 %	10.11 %
2021	65.32 %	8.38 %	-2.58 %
2020	72.04 %	21.47 %	12.76 %
2019	76.74 %	27.42 %	21.96 %
2018	78.27 %	29.38 %	25.19 %
2017	77.68 %	28.57 %	25.73 %
2016	81.66 %	31.35 %	30.56 %
2015	81.44 %	32.42 %	29.44 %
2014	81.03 %	28.26 %	23.8 %
2013	83.56 %	16 %	12.35 %
2012	83.53 %	13.07 %	7.91 %
2011	83.03 %	12.33 %	8.54 %
2010	84.76 %	13.65 %	10.15 %
2009	85.76 %	16.24 %	12.93 %
2008	83.18 %	13.1 %	9.54 %
2007	84.24 %	16.13 %	11.41 %
2006	79.4 %	26.31 %	27.15 %
2005	77.79 %	26.63 %	26.02 %
2004	65.69 %	25.62 %	22.76 %

	브루토마진	EBIT-마진	이익 마진
2004	65.69 %	25.62 %	22.76 %
2005	77.79 %	26.63 %	26.02 %
2006	79.4 %	26.31 %	27.15 %
2007	84.24 %	16.13 %	11.41 %
2008	83.18 %	13.1 %	9.54 %
2009	85.76 %	16.24 %	12.93 %
2010	84.76 %	13.65 %	10.15 %
2011	83.03 %	12.33 %	8.54 %
2012	83.53 %	13.07 %	7.91 %
2013	83.56 %	16 %	12.35 %
2014	81.03 %	28.26 %	23.8 %
2015	81.44 %	32.42 %	29.44 %
2016	81.66 %	31.35 %	30.56 %
2017	77.68 %	28.57 %	25.73 %
2018	78.27 %	29.38 %	25.19 %
2019	76.74 %	27.42 %	21.96 %
2020	72.04 %	21.47 %	12.76 %
2021	65.32 %	8.38 %	-2.58 %
2022	69.22 %	15.32 %	10.11 %
2023	68.44 %	16.83 %	8.67 %
2024e	68.44 %	19.24 %	9.97 %
2025e	68.44 %	20.03 %	11.75 %
2026e	68.44 %	21.2 %	13.17 %

날짜	Luye Pharma Group 주당 매출	Luye Pharma Group EBIT 당 주식	Luye Pharma Group 주당 이익
2026e	2.2 undefined	0 undefined	0.29 undefined
2025e	2 undefined	0 undefined	0.24 undefined
2024e	1.81 undefined	0 undefined	0.18 undefined
2023	1.65 undefined	0.28 undefined	0.14 undefined
2022	1.72 undefined	0.26 undefined	0.17 undefined
2021	1.51 undefined	0.13 undefined	-0.04 undefined
2020	1.73 undefined	0.37 undefined	0.22 undefined
2019	1.97 undefined	0.54 undefined	0.43 undefined
2018	1.61 undefined	0.47 undefined	0.4 undefined
2017	1.17 undefined	0.33 undefined	0.3 undefined
2016	0.88 undefined	0.28 undefined	0.27 undefined
2015	0.77 undefined	0.25 undefined	0.23 undefined
2014	0.85 undefined	0.24 undefined	0.2 undefined
2013	0.95 undefined	0.15 undefined	0.12 undefined
2012	0.8 undefined	0.11 undefined	0.06 undefined
2011	3.6 undefined	0.44 undefined	0.31 undefined
2010	2.72 undefined	0.37 undefined	0.28 undefined
2009	1.94 undefined	0.31 undefined	0.25 undefined
2008	1.32 undefined	0.17 undefined	0.13 undefined
2007	1.03 undefined	0.17 undefined	0.12 undefined
2006	0.67 undefined	0.18 undefined	0.18 undefined
2005	0.84 undefined	0.22 undefined	0.22 undefined
2004	1.05 undefined	0.27 undefined	0.24 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	1.05 CNY	0.27 CNY	0.24 CNY
2005	0.84 CNY	0.22 CNY	0.22 CNY
2006	0.67 CNY	0.18 CNY	0.18 CNY
2007	1.03 CNY	0.17 CNY	0.12 CNY
2008	1.32 CNY	0.17 CNY	0.13 CNY
2009	1.94 CNY	0.31 CNY	0.25 CNY
2010	2.72 CNY	0.37 CNY	0.28 CNY
2011	3.6 CNY	0.44 CNY	0.31 CNY
2012	0.8 CNY	0.11 CNY	0.06 CNY
2013	0.95 CNY	0.15 CNY	0.12 CNY
2014	0.85 CNY	0.24 CNY	0.2 CNY
2015	0.77 CNY	0.25 CNY	0.23 CNY
2016	0.88 CNY	0.28 CNY	0.27 CNY
2017	1.17 CNY	0.33 CNY	0.3 CNY
2018	1.61 CNY	0.47 CNY	0.4 CNY
2019	1.97 CNY	0.54 CNY	0.43 CNY
2020	1.73 CNY	0.37 CNY	0.22 CNY
2021	1.51 CNY	0.13 CNY	-0.04 CNY
2022	1.72 CNY	0.26 CNY	0.17 CNY
2023	1.65 CNY	0.28 CNY	0.14 CNY
2024e	1.81 CNY	0 CNY	0.18 CNY
2025e	2 CNY	0 CNY	0.24 CNY
2026e	2.2 CNY	0 CNY	0.29 CNY

	주식 수량
2004	300.3 백만 Aktien
2005	407.8 백만 Aktien
2006	459.7 백만 Aktien
2007	492.4 백만 Aktien
2008	492.8 백만 Aktien
2009	492.8 백만 Aktien
2010	492.8 백만 Aktien
2011	492.8 백만 Aktien
2012	2.65 조. Aktien
2013	2.65 조. Aktien
2014	2.99 조. Aktien
2015	3.32 조. Aktien
2016	3.32 조. Aktien
2017	3.26 조. Aktien
2018	3.22 조. Aktien
2019	3.22 조. Aktien
2020	3.19 조. Aktien
2021	3.45 조. Aktien
2022	3.48 조. Aktien
2023	3.73 조. Aktien
2024e	3.73 조. Aktien
2025e	3.73 조. Aktien
2026e	3.73 조. Aktien

날짜	Luye Pharma Group 배당금
2020	0.06 undefined
2019	0.13 undefined
2018	0.11 undefined
2017	0.07 undefined
2016	0.04 undefined

	배당금	배당금 (추정)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0.04 CNY	0 CNY
2017	0.07 CNY	0 CNY
2018	0.11 CNY	0 CNY
2019	0.13 CNY	0 CNY
2020	0.06 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0 CNY	0 CNY
2023	0 CNY	0 CNY
2024e	0 CNY	0 CNY
2025e	0 CNY	0 CNY
2026e	0 CNY	0 CNY

날짜	Luye Pharma Group 배당률
2026e	28 %
2025e	28.12 %
2024e	28.05 %
2023	27.82 %
2022	28.49 %
2021	27.85 %
2020	27.12 %
2019	30.48 %
2018	25.96 %
2017	23.91 %
2016	13.78 %
2015	27.85 %
2014	27.85 %
2013	27.85 %
2012	27.85 %
2011	27.85 %
2010	27.85 %
2009	27.85 %
2008	27.85 %
2007	27.85 %
2006	27.85 %
2005	27.85 %
2004	27.85 %

	배당률
2004	27.85 %
2005	27.85 %
2006	27.85 %
2007	27.85 %
2008	27.85 %
2009	27.85 %
2010	27.85 %
2011	27.85 %
2012	27.85 %
2013	27.85 %
2014	27.85 %
2015	27.85 %
2016	13.78 %
2017	23.91 %
2018	25.96 %
2019	30.48 %
2020	27.12 %
2021	27.85 %
2022	28.49 %
2023	27.82 %
2024e	28.05 %
2025e	28.12 %
2026e	28 %

%-지분	이름	주식	변경
4.91 %	E Fund Management Co. Ltd.	184,787,500	-7,958,500
33.47 %	Luye Life Sciences Group Ltd.	1,259,196,703	0
2.43 %	ZhongGeng Fund Management Co., Ltd.	91,319,500	91,319,500
14.68 %	Hillhouse Capital Management Ltd.	552,324,108	0
1.53 %	The Vanguard Group, Inc.	57,397,456	0
1.12 %	Bosera Asset Management Co., Ltd.	42,229,000	10,303,000
1.06 %	GF Fund Management Co., Ltd.	39,926,500	19,217,000
0.93 %	Dimensional Fund Advisors, L.P.	34,874,500	-1,437,500
0.65 %	BlackRock Institutional Trust Company, N.A.	24,607,000	42,000
0.62 %	FIL Investment Management (Hong Kong) Limited	23,238,750	23,238,750
0.32 %	China Asset Management Co., Ltd.	11,987,500	5,879,000
0.20 %	Nordea Funds Oy	7,400,000	-221,500
0.17 %	Jupiter Asset Management Ltd.	6,500,000	-536,500
0.17 %	California State Teachers Retirement System	6,303,000	6,303,000
0.16 %	BlackRock Advisors (UK) Limited	5,920,500	32,000
0.14 %	Dimensional Fund Advisors, Ltd.	5,399,500	0
0.14 %	American Century Investment Management, Inc.	5,307,000	1,033,500
0.13 %	China Asset Management (Hong Kong) Limited	4,940,139	-137,500
0.13 %	State Street Global Advisors (US)	4,858,399	-87,500
0.10 %	China Universal Asset Management Co., Ltd.	3,843,500	1,504,500
0.10 %	China Southern Asset Management Co. Ltd.	3,832,000	-18,616,000
0.10 %	Robeco Institutional Asset Management B.V.	3,766,500	0
0.09 %	PGGM Vermogensbeheer B.V.	3,472,817	2,353,335
0.08 %	Fullgoal Fund Management Co., Ltd.	3,095,000	3,095,000
0.07 %	Penghua Fund Management Co., Ltd.	2,800,000	441,500
0.07 %	State Street Global Advisors (UK) Ltd.	2,515,732	4
0.06 %	Charles Schwab Investment Management, Inc.	2,339,744	0
0.04 %	Nuveen LLC	1,615,000	0
0.03 %	Bellevue Asset Management AG	1,315,000	950,000
0.03 %	BlackRock Investment Management (UK) Ltd.	1,308,500	14,500
0.03 %	Franklin Templeton Investment Management Ltd.	1,200,820	0
0.03 %	Avantis Investors	1,180,000	0
0.03 %	Yinhua Fund Management Co., Ltd.	1,035,500	673,500
0.02 %	Geode Capital Management, L.L.C.	880,500	0
0.02 %	Tianhong Asset Management Co., Ltd.	633,500	633,500
0.01 %	HSBC Global Asset Management (UK) Limited	491,273	-8,348
0.01 %	Legal & General Investment Management Ltd.	487,000	0
0.01 %	Franklin Advisers, Inc.	472,500	94,500
0.01 %	State Street Global Advisors Ireland Limited	464,500	-71,000
0.01 %	DFA Australia Ltd.	427,348	36,848
0.01 %	Riverfront Investment Group, LLC	354,500	0
0.01 %	Western Leadbank Fund Management Co., Ltd.	347,000	-48,500
0.01 %	Hwabao WP Fund Management Co., Ltd.	331,000	331,000
0.01 %	Mirae Asset Global Investments (USA) LLC	326,224	8,500
0.01 %	BlackRock Asset Management North Asia Limited	277,500	0
0.01 %	Parametric Portfolio Associates LLC	249,500	0
0.01 %	Vanguard Global Advisers LLC	202,000	2,000
0.01 %	Guliver Anlageberatung GmbH	200,000	0
0.01 %	Ping An Fund Management Company Limited	196,000	55,000
0.01 %	Vanguard Investments Australia Ltd.	191,054	810
0.00 %	JPMorgan Asset Management (China) Company Limited.	184,500	184,500
0.00 %	Vident Investment Advisory, LLC	173,000	0
0.00 %	Exchange Traded Concepts, LLC	173,000	0
0.00 %	Storebrand Kapitalforvaltning AS	173,000	0
0.00 %	Guotai Asset Management Co., Ltd.	120,000	120,000
0.00 %	UBS Asset Management (UK) Ltd.	118,000	0
0.00 %	Franklin Advisory Services, LLC	118,000	6,000
0.00 %	Franklin Templeton Portfolio Advisors, Inc	94,500	0
0.00 %	Scottish Equity Partners LLP	83,000	0
0.00 %	Grantham Mayo Van Otterloo & Co LLC	74,000	-147,500
0.00 %	HuaAn Fund Management Co., Ltd.	62,500	-7,423,500
0.00 %	BlackRock (Luxembourg) S.A.	31,000	-29,000
0.00 %	Northern Trust Investments, Inc.	24,000	0
0.00 %	Dimensional Fund Advisors Canada ULC	22,000	0
0.00 %	Hang Seng Investment Management Ltd.	12,000	2,000
0.00 %	Krane Funds Advisors, LLC	8,000	0
0.00 %	Invesco Capital Management LLC	3,000	3,000
0.00 %	Norges Bank Investment Management (NBIM)	1,001	-995,494
0.00 %	Eurizon Capital S.A.	992	0
0 %	ASPOMA Asset Management GmbH	0	-236,600
0 %	Truvalue Asset Management Co., Ltd.	0	-197,500
0 %	Finlabo SIM S.p. A.	0	-79,000
0 %	Essence Fund Management Co., Ltd.	0	-4,300,000
0 %	1741 Fund Solutions AG	0	-250,000
0 %	CSOP Asset Management Limited	0	-80,408
0 %	CITIC Prudential Fund Management Co., Ltd.	0	-2,855,622
0 %	INVESCO Great Wall Fund Management Co. Ltd.	0	-40,000
0 %	British Columbia Investment Management Corp.	0	-18,382,672
0 %	Templeton Asset Management Ltd.	0	-4,876,500
0 %	BlackRock Investment Management (Australia) Ltd.	0	-2,000
0 %	APG Asset Management N.V.	0	-9,563,833
0 %	State Street Global Advisors Asia Ltd.	0	-3,093
0 %	HSBC Global Asset Management (Hong Kong) Limited	0	-29,000
0 %	Allianz Global Investors GmbH	0	-195,500
0 %	Nordea Investment Management AB (Denmark)	0	-4,134,000
0 %	BlackRock Financial Management, Inc.	0	-704,000
0 %	PIMCO (US)	0	-16,888,100
0 %	Fidelity Management & Research Company LLC	0	-1,091,798
0 %	Asteria Investment Managers	0	-125,500
0 %	Franklin Templeton International Services SARL	0	-2,668,000

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Essence Info A	공급업체고객	0,70	0,90	0,87	0,83	0,76	-
Lotus Pharmaceutical	공급업체고객	0,62	0,58	-0,69	-0,70	-0,31	-0,56
PharmaMar	공급업체고객	0,53	0,53	-0,84	-0,82	0,45	0,53
Cipla	공급업체고객	0,37	0,78	-0,50	-0,74	-0,21	-0,44
AstraZeneca	공급업체고객	-0,46	0,07	-0,86	-0,89	-0,69	-0,62
Zhejiang Jiuzhou Pharm A	공급업체고객	-0,52	-0,07	-0,34	0,42	-0,24	-0,43
Ocumension	공급업체고객	-0,77	0,21	0,33	0,78	0,92	-
Towa Pharmaceutical	공급업체고객	-0,84	-0,16	0,78	0,39	-0,26	-0,48

What values and corporate philosophy does Luye Pharma Group represent?

Luye Pharma Group Ltd is a renowned pharmaceutical company that upholds strong values and a distinct corporate philosophy. The company focuses on improving the well-being of individuals by providing innovative and high-quality healthcare solutions. Luye Pharma Group Ltd is committed to meeting healthcare needs globally and believes in continuous research and development to deliver cutting-edge pharmaceutical products. With a customer-centric approach, they strive for excellence in manufacturing and commercialization, ensuring affordable and accessible healthcare options. Luye Pharma Group Ltd's core values include integrity, innovation, collaboration, and customer satisfaction, which guide their operations and drive their success in the pharmaceutical industry.

In which countries and regions is Luye Pharma Group primarily present?

Luye Pharma Group Ltd is primarily present in multiple countries and regions worldwide. These include China, where the company is headquartered, as well as the United States, Europe, Asia-Pacific, and other emerging markets. With a global presence, Luye Pharma Group Ltd has established a strong international footprint to cater to diverse markets and provide innovative pharmaceutical solutions.

What significant milestones has the company Luye Pharma Group achieved?

Luye Pharma Group Ltd has achieved several significant milestones. In recent years, the company has successfully expanded its global presence by establishing strategic partnerships and acquiring new assets. Luye Pharma has also made remarkable advances in research and development, with numerous new drug approvals and clinical trial successes. Furthermore, the company has continuously increased its revenue and market share, solidifying its position as a leading pharmaceutical enterprise. Luye Pharma Group Ltd's commitment to innovation and growth has propelled it to become a trusted name in the pharmaceutical industry, inspiring confidence among investors and stakeholders alike.

What is the history and background of the company Luye Pharma Group?

Luye Pharma Group Ltd is a renowned pharmaceutical company with a rich history and background. Established in 1994, Luye Pharma Group has consistently grown and evolved into a leading player in the global pharmaceutical industry. The company is dedicated to developing, manufacturing, and marketing a wide range of innovative and high-quality healthcare products. Luye Pharma Group operates in over 80 countries and regions, with a strong presence in the fields of oncology, cardiovascular, neuropsychiatry, and more. With a commitment to research and development, Luye Pharma Group continues to create sustainable solutions for the ever-changing pharmaceutical landscape, ensuring better health outcomes for people worldwide.

Who are the main competitors of Luye Pharma Group in the market?

Some of the main competitors of Luye Pharma Group Ltd in the market include multinational pharmaceutical companies like Pfizer, Novartis, and Bristol-Myers Squibb. These companies have a strong presence in the global pharmaceutical industry and offer a wide range of products and therapeutic solutions similar to Luye Pharma Group Ltd. However, Luye Pharma Group Ltd has established its unique position in the market through its focus on developing and commercializing innovative drugs and therapeutic solutions, particularly in the areas of oncology, cardiovascular, and central nervous system disorders.

In which industries is Luye Pharma Group primarily active?

Luye Pharma Group Ltd is primarily active in the pharmaceutical industry.

What is the business model of Luye Pharma Group?

Luye Pharma Group Ltd operates under a pharmaceutical business model. The company is primarily focused on the research, development, production, and sale of pharmaceutical products. Luye Pharma Group Ltd specializes in developing and commercializing innovative medicines and therapies in various therapeutic areas. They aim to address unmet medical needs and improve patient outcomes. With their extensive product portfolio, Luye Pharma Group Ltd strives to provide high-quality pharmaceutical solutions globally. By constantly investing in research and development, they aim to stay at the forefront of medical advancements and deliver effective and safe treatments to patients worldwide.

Luye Pharma Group 2024의 P/E 비율은 얼마입니까?

Luye Pharma Group의 P/E 비율은 14.08입니다.

Luye Pharma Group 2024의 KUV는 얼마입니까?

Luye Pharma Group의 P/S 비율은 1.4입니다.

Luye Pharma Group의 AlleAktien 품질 점수는 얼마인가요?

Luye Pharma Group에 대한 AlleAktien 품질 점수는 3/10입니다.

Luye Pharma Group 2024의 매출은 얼마인가요?

예상되는 Luye Pharma Group 매출은 6.79 조. CNY입니다.

Luye Pharma Group 2024의 이익은 얼마인가요?

예상되는 Luye Pharma Group 이익은 677.21 백만 CNY입니다.

Luye Pharma Group은 무엇을 하나요?

Luye Pharma Group Ltd is an internationally operating pharmaceutical company based in China. The company specializes in the development, production, and marketing of innovative drugs and generics in various therapeutic areas. Luye Pharma operates in four main business areas: new drugs and biosimilars, generics, medical devices, and health services. The company aims to offer innovative and cost-effective medications and healthcare services to meet the needs of patients worldwide. Luye Pharma has a strong presence in the global market due to its strong pipeline of products and wide portfolio of existing drugs and devices. The company remains an innovator and a leading player in the global pharmaceutical industry through its continuous investment in research and development.

Luye Pharma Group 배당금은 얼마입니까?

Luye Pharma Group은(는) 연간 번의 배당을 통해 0 CNY의 배당금을 지급합니다.

Luye Pharma Group이 얼마나 자주 배당을 지급하나요?

Luye Pharma Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Luye Pharma Group ISIN이 무엇입니까?

Luye Pharma Group의 ISIN은 BMG570071099입니다.

Luye Pharma Group WKN은 무엇인가요?

Luye Pharma Group의 WKN은 A116Z9입니다.

Luye Pharma Group 티커는 무엇인가요?

Luye Pharma Group의 티커는 2186.HK입니다.

Luye Pharma Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Luye Pharma Group은(는) 0.06 CNY 의 배당금을 지급했습니다. 이는 약 2.35 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Luye Pharma Group은(는) 0 CNY의 배당금을 지급할 것으로 예상됩니다.

Luye Pharma Group의 배당 수익률은 얼마입니까?

Luye Pharma Group의 현재 배당 수익률은 2.35 %입니다.

Luye Pharma Group의 배당금은 언제 지급되나요?

Luye Pharma Group은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Luye Pharma Group의 배당금은 얼마나 안전한가요?

Luye Pharma Group은(는) 지난 3년 동안 매년 배당금을 지급했습니다.

Luye Pharma Group의 배당금은 얼마입니까?

향후 12개월 동안 0 CNY의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Luye Pharma Group이(가) 속해 있는 섹터는 어디인가요?

Luye Pharma Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Luye Pharma Group kaufen, um die vorherige Dividende zu erhalten?

Luye Pharma Group의 마지막 배당금을 0.06 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Luye Pharma Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Luye Pharma Group의 2023년도 배당금은 얼마였습니까?

2023년에 Luye Pharma Group는 0 CNY를 배당금으로 지급했습니다.

Luye Pharma Group는 어떤 화폐로 배당금을 지급하나요?

Luye Pharma Group의 배당금은 CNY에 지급됩니다.

Scope 1 - 직접 방출	10,822.51
스코프 2 - 구매한 에너지로부터의 간접적인 배출	67,258.94
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	78,081.45
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	✅
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	✅
환경 친화적인 포장	❌
위험물질	✅
연료 소비량과 효율성	❌
물 사용량 및 효율성	✅

여성 직원 비율	53.187
관리 직위에서의 여성 비율	—
아시아 직원 비율	—
아시아 경영진 비율	—
히스패닉/라티노 직원 비율	—
히스패닉/라티노 관리 부문 지분	—
흑인 직원 비율	—
블랙 매니지먼트 지분	—
흰색 종업원의 비율	—
화이트 매니지먼트 지분	—
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	✅
개인정보 보호 정책	—
작업 및 건강 보호	✅
카톨릭	✅

환경 보고	✅
이해관계자 참여	✅
콜백 정책	❌
카르텔법	❌

증권거래소	Luye Pharma Group 티커
프랑크푸르트	LUP.F
HKSE	2186.HK
뮌헨	LUP.MU
PNK	LYPHF

Luye Pharma Group 티커	Luye Pharma Group FIGI
2186:HK	BBG006PTKB26
LUP:GR	BBG006SC41C9
LUP:GF	BBG006SC41D8
LUP:GS	BBG006SC41J2
LUP:GM	BBG006SC41K0
LUP:GB	BBG006SC41L9
2186EUR:EO	BBG006SZ26R3
2186EUR:XH	BBG006SZ26V8
2186EUR:XF	BBG006SZ26X6
2186EUR:XE	BBG006SZ26Z4
2186EUR:XJ	BBG006SZ2700
2186EUR:XL	BBG006SZ2719
2186EUR:XG	BBG006SZ2728
2186EUR:XO	BBG006SZ2737
2186EUR:XS	BBG006SZ2773
2186EUR:XA	BBG006SZ2782
2186EUR:E1	BBG006SZ2791
2186EUR:XT	BBG006SZ27B8
2186EUR:XW	BBG006SZ27C7
2186EUR:XU	BBG006SZ27D6
2186EUR:XV	BBG006SZ27G3
2186EUR:EU	BBG006SZ27J0
2186:H1	BBG007PMBRK4
2186:H2	BBG00F135SB9
2186EUR:XX	BBG00JN87B58
2186N:PO	BBG00JRFYM27
2186N:L3	BBG00JRG5Z28
2186N:B3	BBG00JRG6KZ4
2186HKD:X2	BBG00JRGQ7Y2
2186HKD:XB	BBG00JRGQ7Z1
2186HKD:XH	BBG00JRGQ816
2186HKD:XF	BBG00JRGQ834
2186HKD:XE	BBG00JRGQ852
2186HKD:XJ	BBG00JRGQ861
2186HKD:XL	BBG00JRGQ870
2186HKD:XG	BBG00JRGQ889
2186HKD:XO	BBG00JRGQ898
2186HKD:XS	BBG00JRGQ8F1
2186HKD:XA	BBG00JRGQ8G0
2186HKD:E1	BBG00JRGQ8H9
2186HKD:XT	BBG00JRGQ8J7
2186HKD:XW	BBG00JRGQ8K5
2186HKD:XU	BBG00JRGQ8L4
2186HKD:XV	BBG00JRGQ8M3
2186HKD:XM	BBG00JRGQ8N2
2186HKD:XQ	BBG00JRGQ8Q9
2186HKD:XX	BBG00JRGQ8R8
2186HKD:XZ	BBG00JRGQ8S7
2186HKD:EU	BBG00JRGQ8V3
LYPHF:US	BBG00MYZFRL7
LYPHF:PQ	BBG00MYZFS08
LYPHF:UV	BBG00MYZFS17
LUP:GZ	BBG00X2S6HK7
2186EUR:EP	BBG00X2THW02
2186EUR:EZ	BBG00X2THW20
2186N:L1	BBG00Y7B1F44
LUP:LA	BBG018H9C1W2
LUP:LU	BBG018J302N4

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0.24	0.32	0.34	0.31	0.51	0.65	0.95	1.34	1.77	2.14	2.52	2.54	2.56	2.92	3.81	5.17	6.36	5.54	5.2	5.98	6.14	6.79	7.53	8.27
-	32.35	9.21	-10.47	65.26	27.90	46.54	40.46	32.39	20.35	17.80	1.11	0.79	13.81	30.75	35.63	22.89	-12.87	-6.12	15.02	2.71	10.56	10.84	9.90
54.62	65.71	77.62	79.22	84.09	83.10	85.74	84.78	83.03	83.56	83.54	81.05	81.43	81.66	77.69	78.27	76.75	72.03	65.31	69.22	68.44	-	-	-
0.13	0.21	0.27	0.24	0.43	0.54	0.82	1.14	1.47	1.78	2.1	2.06	2.09	2.38	2.96	4.05	4.88	3.99	3.4	4.14	4.2	0	0	0
0.06	0.08	0.09	0.08	0.08	0.09	0.16	0.18	0.22	0.28	0.4	0.72	0.83	0.91	1.09	1.52	1.74	1.19	0.44	0.92	1.03	1.31	1.51	1.75
23.95	25.40	26.45	26.30	16.11	13.06	16.25	13.66	12.29	13.07	15.98	28.23	32.38	31.33	28.58	29.38	27.42	21.47	8.37	15.32	16.83	19.24	20.03	21.20
0.04	0.07	0.09	0.08	0.06	0.06	0.12	0.14	0.15	0.17	0.31	0.61	0.75	0.89	0.98	1.3	1.4	0.71	-0.13	0.6	0.53	0.68	0.88	1.09
-	69.05	25.35	-6.74	-30.12	6.90	98.39	10.57	11.03	11.92	83.43	95.16	24.63	18.17	10.10	32.82	7.14	-49.43	-118.98	-550.75	-11.92	27.26	30.58	23.19
0.32	0.3	0.41	0.46	0.49	0.49	0.49	0.49	0.49	2.65	2.65	2.99	3.32	3.32	3.26	3.22	3.22	3.19	3.45	3.48	3.73	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커2186.HK

ISINBMG570071099

WKNA116Z9

Luye Pharma Group 주식 매출, EBIT, 이익 BMG570071099 · A116Z9

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Luye Pharma Group 매출, 이익 및 EBIT 역사

Luye Pharma Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Luye Pharma Group 주식 마진 BMG570071099 · A116Z9

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Luye Pharma Group 마진 역사

Luye Pharma Group 주식 매출, EBIT, 주당 순이익 BMG570071099 · A116Z9

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Luye Pharma Group 매출, 이익 및 EBIT 주당 역사

Luye Pharma Group 주식 및 주식 분석

Luye Pharma Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

Luye Pharma Group 주식 수량 BMG570071099 · A116Z9

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Luye Pharma Group 주식 배당금 BMG570071099 · A116Z9

배당금

배당금에 대한 개요

해석 및 사용

투자 전략

Luye Pharma Group 배당금 내역

Luye Pharma Group 주식 배당률 BMG570071099 · A116Z9

배당비율

연간 배당비율이란 무엇인가요?

데이터 해석 방법

투자에 대한 데이터 사용

Luye Pharma Group 배당금지급률 역사

Luye Pharma Group 수익 예상

Luye Pharma Group 수익 놀라움

Eulerpool ESG Scorecard© Luye Pharma Group 주식을 위해

Eulerpool World ESG Rating (EESG©)

74/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Luye Pharma Group 주식 주주 구조

Luye Pharma Group 임원진 및 경영진

Luye Pharma Group 공급망

Luye Pharma Group 주식에 대한 자주 묻는 질문

What values and corporate philosophy does Luye Pharma Group represent?

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
2186.HK

ISIN
BMG570071099

WKN
A116Z9